Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine in Paediatric Patients With Myotonic Disorders (Extension Study)
NCT04622553Completed
- Sponsor
- Lupin Limited
- Start
- Nov 2021
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of mexiletine in myotonic disorders, sponsored by Lupin Limited. Primary endpoints: Adverse Events at 24 months, Hand relaxation time at 24 months and 3 more. Started Nov 2021; status: completed.
02
Drugs
mexiletine
03
Conditions
myotonic disorders
Beyond the preview
Go deeper on NCT04622553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04622553.